These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15264177)

  • 1. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality.
    Weiner DE; Tighiouart H; Stark PC; Amin MG; MacLeod B; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2004 Aug; 44(2):198-206. PubMed ID: 15264177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease.
    Weiner DE; Tabatabai S; Tighiouart H; Elsayed E; Bansal N; Griffith J; Salem DN; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2006 Sep; 48(3):392-401. PubMed ID: 16931212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
    Wattanakit K; Coresh J; Muntner P; Marsh J; Folsom AR
    J Am Coll Cardiol; 2006 Sep; 48(6):1183-9. PubMed ID: 16979003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease.
    Vlagopoulos PT; Tighiouart H; Weiner DE; Griffith J; Pettitt D; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2005 Nov; 16(11):3403-10. PubMed ID: 16162813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
    Hubbard D; Colantonio LD; Rosenson RS; Brown TM; Jackson EA; Huang L; Orroth KK; Reading S; Woodward M; Bittner V; Gutierrez OM; Safford MM; Farkouh ME; Muntner P
    Cardiovasc Diabetol; 2021 Mar; 20(1):58. PubMed ID: 33648518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N; Cerain-Herrero MJ; Subirana I; Rodríguez-Latre LM; Cunillera-Puértolas O; Mestre-Ferrer J; Grau M; Dégano IR; Elosua R; Marrugat J; Ramos R; Baena-Díez JM; Salvador-González B
    Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):212-218. PubMed ID: 30709697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
    Wannamethee SG; Shaper AG; Lennon L
    Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
    Weiner DE; Tighiouart H; Amin MG; Stark PC; MacLeod B; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2004 May; 15(5):1307-15. PubMed ID: 15100371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of aortic root dimension in persons > or = 65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study).
    Gardin JM; Arnold AM; Polak J; Jackson S; Smith V; Gottdiener J
    Am J Cardiol; 2006 Jan; 97(2):270-5. PubMed ID: 16442377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.
    Bansal N; Katz R; Robinson-Cohen C; Odden MC; Dalrymple L; Shlipak MG; Sarnak MJ; Siscovick DS; Zelnick L; Psaty BM; Kestenbaum B; Correa A; Afkarian M; Young B; de Boer IH
    JAMA Cardiol; 2017 Mar; 2(3):314-318. PubMed ID: 28002548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes.
    Hero C; Rawshani A; Svensson AM; Franzén S; Eliasson B; Eeg-Olofsson K; Gudbjörnsdottir S
    Diabetes Care; 2016 Jun; 39(6):996-1003. PubMed ID: 27208327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and subsequent kidney disease.
    Elsayed EF; Tighiouart H; Griffith J; Kurth T; Levey AS; Salem D; Sarnak MJ; Weiner DE
    Arch Intern Med; 2007 Jun; 167(11):1130-6. PubMed ID: 17563020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
    Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
    Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
    Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of chronic kidney disease and increased arterial stiffness is a predictor for stroke and cardiovascular disease in hypertensive patients.
    Ohishi M; Tatara Y; Ito N; Takeya Y; Onishi M; Maekawa Y; Kato N; Kamide K; Rakugi H
    Hypertens Res; 2011 Nov; 34(11):1209-15. PubMed ID: 21814210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.